Melbourne researchers have shown a type of leukaemia can be successfully ‘reversed’ by coaxing the cancer cells back into normal development.
The discovery was made using a model of B-progenitor acute lymphoblastic leukaemia (B-ALL), the most common cancer affecting children.
Researchers from the Walter and Eliza Hall Institute showed that switching off a gene called Pax5 could cause cancer in a model of B-ALL, while restoring its function could ‘cure’ the disease.
Institute researchers Dr Ross Dickins and Ms Grace Liu led the study with institute colleagues and collaborators in Vienna. The study was published today in the journal Genes & Development.
Ms Liu said the team used a newly developed ‘genetic switch’ technology to inhibit then reactivatePax5 in the leukaemia model.
“Along with other genetic changes, deactivating Pax5 drives normal blood cells to turn into leukaemia cells, which has been shown before,” Ms Liu said. “However we showed for the first time that reactivating Pax5 enabled the cells to resume their normal development and lose their cancer-like qualities, effectively curing the leukaemia. What was intriguing for us was that simply restoring Pax5 was enough to normalise these cancer cells, despite the other genetic changes.”
Read more . . .
The Latest on: Gene switch reverses cancer
[google_news title=”” keyword=”Gene switch reverses cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Gene switch reverses cancer
- Cell & Gene Therapyon March 19, 2024 at 5:00 pm
Our research on cell-based therapies also includes cutting-edge immunotherapies that harness the patient’s own immune cells to fight disease, including genetic engineering of immune cells to attack ...
- Gene Therapy Newson March 18, 2024 at 5:00 pm
Genetic Signature May Predict Response to Immunotherapy for Non-Small Cell Lung Cancer Feb. 23, 2024 — A new study identified a set of 140 genes that may help predict enhanced disease-free ...
- Gene-expression Profiling in Pancreatic Canceron March 18, 2024 at 5:00 pm
The genomic characterization of pancreatic cancer precursor forms and gene signatures of different types of tumors in the pancreas is a challenge still faced. The use of results compiled during ...
- 'I inherited my breast cancer gene from my Dad - I made decision to have both breasts removed'on March 14, 2024 at 4:25 am
Naturally, I was over the moon to find out I didn’t have breast cancer, but I was devastated to discover I had the BRCA2 gene – putting me at greater risk of breast cancer in the future.
- Olivia Munn's BRCA gene test that saved her life amid breast cancer diagnosis explainedon March 13, 2024 at 11:31 am
Olivia Munn has been diagnosed with breast cancer, and it appears that the BRCA gene test she had done as a preventative measure actually saved her life. The 43-year-old Oklahoma-born actress ...
- I Took a Gene Test. The Results Left Me Shocked—and Empoweredon March 12, 2024 at 6:25 am
The BRCA1 and BRCA2 genes on their own don't cause cancer—we all have them. However, a BRCA mutation, like I have, increases the risk of developing breast, ovarian and other types of cancer.
- Immune Cell Gene Therapy Explainedon March 5, 2024 at 4:00 pm
Immunotherapy is a cancer treatment that uses your immune system to find and kill cancer cells. There are different ways to make this happen, and immune cell gene therapy is one of those ways.
- Study: How fusion proteins hijack gene regulators to spur childhood canceron March 5, 2024 at 4:00 pm
As a result, genes that should be activated get repressed and genes that should be repressed get activated, causing cancer. University at Buffalo researchers have now shed more light on the molecular ...
- Inherited Genetic Variants Influence Cancer Cell Gene Expressionon March 4, 2024 at 4:00 pm
Researchers at Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center and Human Genome Sequencing Center investigated the extent to which forms of genetic variation called germline or ...
- Genetic germline variations influence expression of cancer cell geneson March 3, 2024 at 4:00 pm
Researchers at Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center and Human Genome Sequencing Center investigated the extent to which forms of genetic variation called germline or ...
via Bing News